Please login to the form below
Sharp
This page shows the latest Sharp news and features for those working in and with pharma, biotech and healthcare.
MSD wins key EU approval for Keytruda, Alimta combo
Marking a first in Europe, Merck Sharp &Dohme (MSD)'s Keytruda can now be used in the three-way combination, becoming the first to be approved as a first-line use
Latest news
-
UDG Healthcare flogs Aquilant after share drop
Proceeds from the transaction will be funding the continued development of the group’s high-margin divisions, Ashfield and Sharp. ... Sharp also delivered similar results, presenting double digital operating profit growth ahead of the same quarter last
-
New cancer drugs can’t quite plug the revenue hole at AZ
Chief executive Pascal Soriot said the company’s “rich pipeline and sharp commercial focus make us confident that we have in place the right conditions for our return to growth this
-
UDG Healthcare acquires two New-York-based healthcare agencies
The Dublin-based company operates across three divisions – Ashfield, Sharp and Aquilant – and currently employs 9, 000 people with operations in 24 countries.
-
Brexit fears grow for small-to-medium pharma
The new survey of 50 respondents shows sentiment has shifted, with a sharp increase in those saying “We do not have any expectation, ”up to 26% from 18% last time.
-
AZ and MSD surpass rivals with updated Lynparza data
AstraZeneca’s (AZ) and Merck Sharp &Dohme’s (MSD) push for first-line setting for its revamped PARP inhibitor Lynparza (olaparib) has been bolstered by some positive phase III data.
More from news
Approximately 1 fully matching, plus 208 partially matching documents found.
Latest Intelligence
-
China: AstraZeneca’s new engine for growth and innovation
That was a sharp increase from last year’s growth of 15% and 16% respectively, and AZ is now recording $1bn in revenue per quarter in the country.
-
Accelerating innovation
At the sharp end of this challenge is Ipsen’s chief scientific officer and executive VP, research and development, Alexandre Lebeaut.
-
A rare talent
The affordability question. Winter, with its flu crises and bed shortages, brings the UK's healthcare spending into sharp relief, but the affordability question facing the NHS isn't a seasonal
-
Turning the tide on change
results. Louise Sharp is founder and managing director of Makara Health Communications and Makara Training Academy.
-
Oral biologics delivery still elusive
As the intestines don't have sharp pain receptors the delivery goes unnoticed by the patient and - according to the company - the lesion caused in the lining of the GI tract
More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest appointments
-
Ashfield, Health Unlimited and Ashley Communications adds to their teams
He has also served as the executive director for primary care, general medicine at Merck Sharp &Dohme (MSD).
-
Editas Medicine adds to its board of directors
Dr Hopfield has more than two decades worth of experience in the medical and healthcare fields and she has held management positions at Merck Sharp &Dohme ( MSD) in clinical development, outcomes
-
Makara Health appoints Louise Finke as a director
Louise Sharp, founder and managing director of Makara Health, said: “Finke’s considerable experience, strategic approach and industry knowledge make her a perfect fit for Makara as the company continues to
-
Storm Therapeutics bolsters its team
Dr Paul Leeson also joins the University of Cambridge spin-out, following 35 years’experience of drug discovery and development in senior roles in pharmaceutical companies including GlaxoSmithKline, Merck Sharp and
-
Andy Busch joins Shire as its CSO and head of research and development
populations, ”. “This is a unique time to join Shire, as it has built an industry-leading pipeline of rare disease programmes in recent years and has a sharp focus on serial
More from appointments
Approximately 0 fully matching, plus 25 partially matching documents found.
Latest from PMHub
-
Digital trends in B2B sales - how far behind is Pharma?
This is also transforming what sales organizations look like, with a sharp reduction in field sales and marketing, and rapid growth in inside sales and analytics teams.”.
-
Training the next generation of biotech leaders
In June 2016 the UK voted to leave the EU, prompting a new direction for Britain’ s industrial strategy and a sharp focus on biotech and life sciences – fuelled by leading
-
What pharma marketers can learn from growth hacking?
Growth. The purpose of a growth hacker is laser-sharp, it’ s all about growth.
-
Biotech: it's a people business
Here she explains how a sharp focus on patients’ needs is driving a new operating model for marketing first-in-class drugs, and she describes how her mother’ s experience as
-
Improving medication adherence by increasing health literacy
While these numbers for low health literacy are high, they provide a sharp insight into the problem of low therapy adherence.
More from PMHub
Approximately 0 fully matching, plus 29 partially matching documents found.
Featured jobs
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Scientific Team Lead
-
Competitive Salary
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Account Director
-
Negotiable
- Experienced Editor, London, Medical Communications
-
Competitive package
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
-
Account Director - Digital
-
Great salary and benefits
- Account Director – Global Healthcare PR
-
Salary TBC
-
Associate Medical Director
-
Salary TBC
- Director Healthcare PR Communications
-
Salary TBC
-
Scientific Director
-
Highly Competitive Salary &Benefits
-
Associate Medical Director
-
Highly Competitive
- Account Manager, Healthcare Advertising
-
Salary TBC
Subscribe to our email news alerts
- Shire’s angioedema drug Takhzyro recommended in Europe
- Cuttsy+Cuttsy launch their latest patient e-book
- McCann Health London launch Urban Eye Test
- Encouraging data for GenSight’s blinding retinal disease gene therapy
- Keytruda hits survival targets in first-line kidney cancer
- UK ‘unicorn’ Oxford Nanopore bags $65m backing from Amgen
PMHub
Solaris Health
The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...
Latest intelligence
- Retaining reader value in plain language summaries of clinical studies
- Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
- Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
- Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
- Making Europe a leader in bioscience: boosting trust and opening minds
- A vision of Paris as Europe's leading hub for life sciences innovation...
Quick links
Infographics
